EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Salvaging the No-Reflow Zone: Intra-arterial Cranial Bone-Derived MSCs Restore Neurovascular Integrity After Stroke

Takeshi Hara, Masaaki Takeda, Masashi Kuwabara, Yuyo Maeda, Shingo Matsuda, Hiroki Takahashi, Takeshi Imura, Tomoyuki Kurose, Seiji Hama, Takafumi Mitsuhara, Nobutaka Horie

Translational Stroke Research · 2026

DOI: 10.1007/s12975-026-01494-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2026. Verfasst von Takeshi Hara und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Hiroshima, 732-8551, Japan. thara@…. Hauptthemen laut MEDLINE: Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells, Stroke. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hiroshima University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Successful macrovascular recanalization does not always translate into functional recovery, in part because early post-reperfusion injury can drive infarct expansion. Here, we investigated whether hyperacute intra-arterial transplantation of human cranial bone-derived mesenchymal stem cells (hcMSCs) immediately after reperfusion improves functional recovery after ischemic stroke. Transient middle cerebral artery occlusion was induced in adult rats, followed by intra-arterial administration of hcMSCs or vehicle immediately after reperfusion. Neurological and motor pathway recovery were assessed longitudinally using the modified neurological severity score and transcranial motor-evoked potentials. During the acute phase, molecular and histological analyses of peri-infarct tissue were performed and the transcriptomic profiles of hcMSCs compared with those of human bone marrow-derived mesenchymal stem cells (hbMSCs). Hyperacute intra-arterial hcMSC transplantation resulted in significantly faster neurological recovery compared with controls, accompanied by enhanced electrophysiological recovery of motor pathway function. These functional improvements were associated with preservation of neuronal structural integrity in the peri-infarct cortex, attenuation of inflammatory cytokines and apoptosis activity, and vascular endothelial growth factor upregulation. Further, transcriptomic analysis revealed that hcMSCs are enriched in neurotrophic, angiogenic, and immunoregulatory factors, providing a biological support for the observed therapeutic effects. Hyperacute intra-arterial hcMSC delivery immediately after reperfusion promotes functional and electrophysiological recovery in an experimental reperfusion model, likely through early modulation of inflammatory and apoptotic responses in the peri-infarct tissue. These findings support further investigation of hcMSC therapy as a biologically protective adjunctive strategy in the immediate post-recanalization setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem Cell TransplantationMesenchymal Stem CellsStrokeAnimalsMaleRecovery of FunctionRatsHumansDisease Models, AnimalRats, Sprague-DawleyInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

Intra-arterialIschemic strokeMesenchymal stem cellMotor-evoked potentialsReperfusion

Autor:innen und Institutionen

  • Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Hiroshima, 732-8551, Japan. thara@hiroshima-u.ac.jp.
  • Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Kasumi 1-2-3, Hiroshima, 732-8551, Japan.
  • Department of Neurorehabilitation and Emotional Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Anatomy and Histology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Neurosurgery, Hibino Hospital, Hiroshima, Japan.
  • Center of Brain, Mind and KANSEI Sciences Research, Hiroshima University, Hiroshima, Japan.

Förderung

  • Hiroshima University

Zitieren

APA

Hara, T., Takeda, M., Kuwabara, M., Maeda, Y., Matsuda, S., Takahashi, H., Imura, T., Kurose, T., Hama, S., Mitsuhara, T., & Horie, N. (2026). Salvaging the No-Reflow Zone: Intra-arterial Cranial Bone-Derived MSCs Restore Neurovascular Integrity After Stroke. Translational Stroke Research. https://doi.org/10.1007/s12975-026-01494-x

Vancouver

Hara T, Takeda M, Kuwabara M, Maeda Y, Matsuda S, Takahashi H, et al. Salvaging the No-Reflow Zone: Intra-arterial Cranial Bone-Derived MSCs Restore Neurovascular Integrity After Stroke. Translational Stroke Research. 2026. doi:10.1007/s12975-026-01494-x

BibTeX
@article{Hara2026,
  author = {Hara, Takeshi and Takeda, Masaaki and Kuwabara, Masashi and Maeda, Yuyo and Matsuda, Shingo and Takahashi, Hiroki and Imura, Takeshi and Kurose, Tomoyuki and Hama, Seiji and Mitsuhara, Takafumi and Horie, Nobutaka},
  title = {Salvaging the No-Reflow Zone: Intra-arterial Cranial Bone-Derived MSCs Restore Neurovascular Integrity After Stroke},
  journal = {Translational Stroke Research},
  year = {2026},
  doi = {10.1007/s12975-026-01494-x}
}
Kostenlos starten →